

IP29: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology IV
Saturday, May 16, 2026 7:00 AM to 9:00 AM · 2 hr. (America/New_York)
147A
Poster and Podium Sessions
BPHNew Technologies/Instruments/Devices
Saturday, May 16
IP29-01: Quantitative Evaluation of Continuous Bladder Irrigation Through Automated Monitoring
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-02: Durability and long-term outcomes of the prostatic urethral lift (UroLift): a multi-surgeon retrospective analysis of 1990 cases
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-03: Evolution of Surgical Management for Benign Prostatic Obstruction: A Decade of Real-World Data Revealing the Shift from TURP to Laser Enucleation
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-04: COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND ROBOT ASSISTED SIMPLE PROSTATECTOMY FOR BENIGN PROSTATIC HYPERPLASIA
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-05: Interim Analysis of a Multicenter Randomized Trial on Patient-Initiated Preoperative Pelvic Floor Physical Therapy to Reduce Transient Stress Urinary Incontinence Following Holmium Laser Enucleation of the Prostate
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-06: Randomized Control Trial of BPH TURBO procedure using the OptilumeBPH system with 3 Block Techniques – First World Reporting of Out-Patient In-Office Experience Under Local Anesthesia
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-07: Symptom-Free Rate After Prostatic Artery Embolization and Impact of Cardiovascular Risk Factors
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-08: Impact of Ice Chilled Saline Catheter Balloon and Bladder Irrigation on Perioperative Hemostasis, Pain, and Recovery Following Aquablation Therapy for BPH: A Novel Contemporary Comparative Series
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-09: Identifying Predictors of Retreatment and the Optimal Prostate Size Following Convective Water Vapor Thermal Therapy
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-10: Learning Curve of Aquablation: Insights from the First 252 Consecutive Cases in a High-Volume European Centre
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-11: Same-Day Discharge after HoLEP: A Community Experience from our first 100 cases at a Rural Small Ambulatory Surgical Center.
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-12: Less Is More: Smaller Sheath Size Reduces Complications Without Compromising Efficiency in Laser Enucleation of the Prostate
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-13: The prostate elasticity cause lower urinary tract symptoms and dysfunctions independently
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-14: The Impact of Convective Water Vapor Thermal Therapy (Rezum) on Male Sexual Function: A Systematic Review and Meta-Analysis
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-15: Confidence vs Competency: A Multicenter Evaluation of Surgical Skill Attainment in Laser Enucleation of the Prostate Training, A Prostate Enucleation Collaborative Initiative
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-16: HoLEP and Its Miniaturized Variants Provide Superior Perioperative and Postoperative Outcomes Compared to TURP: A Systematic Review and Meta-analysis
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-17: National multicenter prospective study on blue laser vaporization of the prostate for benign prostatic hyperplasia using the ejaculation preservation method (with 3-month follow-up results)
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-18: Ejaculation-Sparing Techniques in Bladder Outlet Obstruction Procedures: A Systematic Review and Meta-analysis
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-19: Histoblast: Preliminary Medium-Term Outcomes of a Modified HIFU Technique for Benign Prostatic Hyperplasia Treatment – A Case Series
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-20: Variation in Discussion of Recovery and Treatment Durability Across Surgical Options for BPH
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-21: Reproducibility of Aquablation Outcomes Across Surgeon Experience Levels: A Pooled Multicenter Comparative Analysis
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-22: Prior Prostate Surgery is an Independent Risk Factor for Urinary Incontinence, Weak Stream and Bothersome Urinary Symptoms in the Early Postoperative Period after Holmium Laser Enucleation of Prostate.
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-23: Temporal and Geographic Trends in Surgical Management of Benign Prostatic Hyperplasia in the US Veteran Population
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-24: Retrospective analysis of minimally invasive laser enucleation of the prostate (MiLEP) using a thulium fiber laser with slim and ultra-slim resectoscopes
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-25: Incidental Prostate Cancer Following HoLEP: Institutional Outcomes and Early Experience With PSA-Based Surveillance With Minimum 2 Years of Follow-Up
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-26: Safety and Feasibility of Holmium Laser Enucleation of the Prostate in Octogenarians and Nonagenarians with Large Glands: A Multicenter Study
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-27: Patient Satisfaction after 12 Months using the Zenflow Spring System for treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-28: Incorporation of Real-time Quantitative Force Feedback within a Hydrogel HoLEP Benchtop Simulator
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-29: Multi-Institutional Learning Curve of Single Port Transvesical Robotic Simple Prostatectomy from the Single Port Advanced Research Consortium (SPARC)
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
IP29-30: Water Vapor Therapy (Rezum) in the Management of Benign Prostatic Hyperplasia: Still Room for Improvement (Technique Modification)
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Hamad Alakrash · Prince Sultan Military Medical City


